23andMe Wants To Use DNA Results To Help Develop More Effective Drug Treatments

Swabbing your saliva with home DNA kits could lead to more than finding out your own ancestral breakdown. Announced on July 25, 23andMe has received a $300 million investment from GlaxoSmithKline, the sixth largest pharmaceutical company in the world. The four-year deal will give GlaxoSmithKline (GSK) access to 23andM
Source: Read Full Article